Ragweed Pollen Allergy - Pipeline Review, H2 2017

Publisher Name :
Date: 08-Aug-2017
No. of pages: 33
Inquire Before Buying

Ragweed Pollen Allergy - Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ragweed Pollen Allergy - Pipeline Review, H2 2017, provides an overview of the Ragweed Pollen Allergy (Immunology) pipeline landscape.

Ragweed allergy occurs when ragweed pollen in the air enters the nose and throat of people who are allergic to that pollen, it can cause allergy and asthma symptoms. Symptoms include sneezing, runny or stuffy nose, itchy throat or inside of ears, hives, and swollen eyelids and itchy eyes. Treatment includes decongestant, antihistamine and nasal corticosteroid.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Ragweed Pollen Allergy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Ragweed Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Ragweed Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Ragweed Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Preclinical and Unknown stages are 1, 4 and 1 respectively.

Ragweed Pollen Allergy (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Ragweed Pollen Allergy (Immunology).

- The pipeline guide reviews pipeline therapeutics for Ragweed Pollen Allergy (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Ragweed Pollen Allergy (Immunology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Ragweed Pollen Allergy (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Ragweed Pollen Allergy (Immunology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Ragweed Pollen Allergy (Immunology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Ragweed Pollen Allergy (Immunology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Ragweed Pollen Allergy - Pipeline Review, H2 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Ragweed Pollen Allergy - Overview
Ragweed Pollen Allergy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Ragweed Pollen Allergy - Therapeutics Assessment
Assessment by Route of Administration
Assessment by Molecule Type
Ragweed Pollen Allergy - Companies Involved in Therapeutics Development
ALK-Abello A/S
Anergis SA
ASIT Biotech SA
Astellas Pharma Inc
Biomay AG
Ragweed Pollen Allergy - Drug Profiles
AllerR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BM-34 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Multi-LAMP-Vax - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PL-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rag-ASIT - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
short ragweed pollen (Ambrosia artemisiifolia) allergen extract ODT - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Ragweed Pollen Allergy - Dormant Projects
Ragweed Pollen Allergy - Discontinued Products
Ragweed Pollen Allergy - Product Development Milestones
Featured News & Press Releases
Feb 16, 2017: ALK submits registration application for ragweed SLIT-tablet in Europe
Dec 19, 2014: Anergis Granted U.S. Patent for Ragweed Allergy Vaccine AllerR
May 15, 2014: Ragwitek, An Allergy Immunotherapy Tablet For The Treatment Of Signs And Symptoms Of Ragweed Allergy, Is Now Available In Canada
Apr 17, 2014: FDA Approves Merck's RAGWITEK Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults
Jan 24, 2014: ALK announces posting of briefing documents for FDA Advisory Committee meeting on the ragweed sublingual tablet
May 08, 2013: Merck Announces FDA Acceptance Of Biologics License Application For Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet
Mar 11, 2013: ALK's Partner Merck Submits BLA To FDA For Marketing Authorization For Ragweed AIT
Feb 22, 2013: Merck To Present New Data Analyses Of Its Investigational Ragweed Pollen And Grass Pollen Allergy Immunotherapy Tablets At 2013 AAAAI Annual Meeting
Feb 21, 2013: Anergis To Present Preclinical Data On Ragweed Allergy Vaccine Candidate AllerR At AAAAI 2013 Annual Meeting
Jun 14, 2012: Anergis Reaches Several Preclinical Development Milestones With Ragweed Pollen Vaccine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Ragweed Pollen Allergy, H2 2017
Number of Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Ragweed Pollen Allergy - Pipeline by ALK-Abello A/S, H2 2017
Ragweed Pollen Allergy - Pipeline by Anergis SA, H2 2017
Ragweed Pollen Allergy - Pipeline by ASIT Biotech SA, H2 2017
Ragweed Pollen Allergy - Pipeline by Astellas Pharma Inc, H2 2017
Ragweed Pollen Allergy - Pipeline by Biomay AG, H2 2017
Ragweed Pollen Allergy - Dormant Projects, H2 2017
Ragweed Pollen Allergy - Discontinued Products, H2 2017

List of Figures
Number of Products under Development for Ragweed Pollen Allergy, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
  • Allergic Rhino-Conjunctivitis - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Allergic Rhino-Conjunctivitis - Market Insights, Epidemiology and Market Forecast - 2025" Reports provides an overview of the disease and global market size of the Allergic Rhino-Conjunctivitis for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Allergic Rhino-Conjunctivitis forecasted market share for ten years to 2025 segmented by seven major markets. In addition, t......
  • Peanut Allergy - Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight's "Peanut Allergy -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Peanut Allergy in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Peanut Allergy. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Peanut Allergy. The report contains the targeted patient populations and the......
  • Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 40
    DelveInsight's, Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Peanut Allergy. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Peanut Allergy which can turn out t......
  • Birch Pollen Allergy - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Birch Pollen Allergy-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Birch Pollen Allergy. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Birch Pollen Allergy by development stage, therapy type, route of administration and molecule type is also covered in the report......
  • Global Allergic Rhinitis Partnering 2010-2017
    Published: 01-Nov-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Allergic Rhinitis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides u......
  • Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Rhino-Conjunctivitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Rhino-Conjunctivitis wh......
  • Allergic Rhino - Conjunctivitis - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, " Allergic Rhino-Conjunctivitis -Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this Allergic Rhino-Conjunctivitis. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Allergic Rhino-Conjunctivitis. This report provides information on the therapeutic development for Allergic Rhino-Conjunctivitis, dealing with all the pipeline drugs and comparative analysis......
  • Seasonal Allergic Rhinitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2250 Onwards        Pages: 120
    DelveInsight's, Seasonal Allergic Rhinitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Seasonal Allergic Rhinitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Seasonal Al......
  • Peanut Allergy - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Peanut Allergy-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Peanut Allergy. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Peanut Allergy by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a sp......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs